Company profile for Intellia Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Many of us pursuing work in the biotechnology industry are inspired by someone in our community who is living with a disease or the loss of a loved one. We know that rare and genetic diseases not only affect the people living with often debilitating and life-threatening symptoms, but that these disorders also significantly impact their families, friends and caregivers. Since the emergence of the breakthrough genome editing ...
Many of us pursuing work in the biotechnology industry are inspired by someone in our community who is living with a disease or the loss of a loved one. We know that rare and genetic diseases not only affect the people living with often debilitating and life-threatening symptoms, but that these disorders also significantly impact their families, friends and caregivers. Since the emergence of the breakthrough genome editing technology CRISPR/Cas9, the science has moved fast in only a few years.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
40 Erie Street, Cambridge, MA 02139
Telephone
Telephone
857-285-6200
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/05/3200972/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
05 Dec 2025

https://www.globenewswire.com/news-release/2025/11/08/3184092/0/en/Intellia-Therapeutics-Presents-Positive-Pooled-Phase-1-2-Data-of-Lonvoguran-Ziclumeran-lonvo-z-in-Patients-with-Hereditary-Angioedema.html

GLOBENEWSWIRE
08 Nov 2025

https://www.biospace.com/drug-development/patient-dies-after-receiving-intellias-crispr-gene-therapy-candidate

BIOSPACE
07 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3183035/0/en/Intellia-Therapeutics-Announces-Third-Quarter-2025-Financial-Results-and-Recent-Updates.html

GLOBENEWSWIRE
06 Nov 2025

https://www.fiercebiotech.com/biotech/fda-places-intellia-phase-3-crispr-trials-hold-over-raised-liver-enzymes

FIERCE BIOTECH
30 Oct 2025

https://www.globenewswire.com/news-release/2025/10/03/3161199/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
03 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty